On ECHEMI
Home > Drugs > Oxytetracycline Hydrochloride Capsules

Oxytetracycline Hydrochloride Capsules

Function and Efficacy

Not yet clear.

Ingredients

The oxytetracycline hydrochloride contained in this product should be 90.0% to 110.0% of the labeled amount calculated as oxytetracycline.

Name Description Content CAS NO. Manufacturer
OxytetracyclineIngredients

Not yet clear

More
79-57-2 34
Oxytetracycline hydrochlorideIngredients

Not yet clear

More
2058-46-0 24

Appearance

This product is a capsule with yellow contents.

Indication

1. This product can be used as a drug of choice for the following diseases: (1) Rickettsial diseases, including epidemic typhus, endemic typhus, Rocky Mountain fever, scrub typhus and Q fever. (2) Mycoplasma infections. (3) Chlamydia infections, including psittacosis, venereal diseases, lymphoedema, nonspecific urethritis, salpingitis, cervicitis and trachoma. (4) Relapsing fever. (5) Brucellosis. (6) Cholera. (7) Tularemia. (8) Plague. (9) Chancroid. It should be used in combination with aminoglycosides for the treatment of brucellosis and plague. 2. Due to the serious drug resistance of common pathogens to this product, it can be used as a drug of choice only when the pathogens are sensitive to this product: Escherichia coli, Enterobacter aerogenes, Acinetobacter rofi, Shigella, Haemophilus influenzae (limited to

Usage and Dosage

Adults: 300 mg orally every 12 hours; children over 8 years old: 5 mg/kg body weight every 12 hours.

Adverse Reactions

1. Digestive system: Gastrointestinal symptoms such as nausea, vomiting, upper abdominal discomfort, bloating, diarrhea, and occasional reports of pancreatitis, esophagitis, and esophageal ulcers, mostly occur in patients who are bedridden immediately after taking the drug. 2. Hepatotoxicity: Usually fatty liver degeneration. Pregnant women and patients with pre-existing renal impairment are prone to hepatotoxicity, but hepatotoxicity can also occur in patients without the above conditions. 3. Allergic reactions: Mostly maculopapular rashes and erythema. In addition, urticaria, angioedema, allergic purpura, pericarditis, and exacerbation of systemic lupus erythematosus can be seen. Exfoliative dermatitis is not common. Occasionally, anaphylactic shock and asthma occur. Some patients using tetracycline have photosensitivity when exposed to the sun. Therefore, patients should be advised not to expose themselves directly to sunlight or ultraviolet rays, and to stop taking the drug immediately if erythema appears on the skin. 4. Blood

Precautions

Patients with a history of allergy to tetracyclines are contraindicated.

Special Population Medication

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

Drug Interactions

Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.

Storage

Keep sealed and stored in a dry place.

Packaging Specification

0.25 g (250,000 units)

Validity Period

24 months

Manufacturer

Changchun Dazheng Tec-Phar Co., Ltd.

  • Founded in:

    2003-12-23
  • Address:

    5km of Changha Highway, Xinglongshan Town, Economic Development Zone
  • Tax NO.:

    9122010175615179X7
  • Registered Funds:

    40 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.